drugset / Trial / NCT00244439

Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice

NCT00244439

Phase 3 Completed 360 enrolled Sun Pharmaceutical Industries, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

Current treatments for head lice include over-the-counter products such as permethrin and prescription products such as OVIDE (malathion 0.5%) lotion. In a previous phase II study, a novel, easy-to-use malathion 0.5% formulation was found to be a safe treatment for head lice. The current study will compare the efficacy and safety of this novel formulation of malathion with OVIDE and with an over-the-counter permethrin product.

Timeline

Start
2005-12
Primary completion
2006-10
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Malathion Small molecule 0.05 %
Comparator Permethrin Small molecule 1 %